Prediction of Tumor Recurrence by F-18-FDG PET in Liver Transplantation for Hepatocellular Carcinoma
- Authors
- 권현우; Kwon, Hyun Woo
- Issue Date
- 5월-2009
- Publisher
- SOC NUCLEAR MEDICINE INC
- Keywords
- FDG; liver transplantation; PET; recurrence; prognosis
- Citation
- JOURNAL OF NUCLEAR MEDICINE, v.50, pp.682 - 687
- Indexed
- SCOPUS
- Journal Title
- JOURNAL OF NUCLEAR MEDICINE
- Volume
- 50
- Start Page
- 682
- End Page
- 687
- URI
- https://scholar.korea.ac.kr/handle/2021.sw.korea/104585
- DOI
- 10.2967/jnumed.108.060574
- ISSN
- 0161-5505
- Abstract
- Although several prognostic factors are used to predict recurrence and to select adequate candidates for liver transplantation for hepatocellular carcinoma (HCC), these prognostic factors have some clinical limitations. The purpose of this study was to evaluate F-18-FDG PET as a prognostic factor and to optimize its ability to predict tumor recurrence in liver transplantation for HCC. Methods: The study included a total of 59 HCC patients (45 men and 15 women; mean age +/- SD, 56 +/- 8 y) who under-went F-18-FDG PET and subsequent orthotopic liver transplantation. All patients were followed up for more than 1 y (mean, 29 +/- 17 mo), and recurrence of tumor was monitored. Three PET parameters-maximal standardized uptake value (SUVmax), ratio of tumor SUVmax to normal-liver SUVmax (T-SUVmax/L-SUVmax), and ratio of tumor SUVmax to normal-liver mean SUV (T-SUVmax/L-SUVmean)-were tested as prognostic factors and compared with conventional prognostic factors. Results: Among the 3 parameters tested, T-SUVmax/L-SUVmax was the most significant in the prediction of tumor recurrence, with a cutoff value of 1.15. In a multivariate analysis of various prognostic factors including T-SUVmax/L-SUVmax, serum alpha-fetoprotein, T stage, size of tumor, and vascular invasion of tumor, T-SUVmax/L-SUV
- Files in This Item
- There are no files associated with this item.
- Appears in
Collections - College of Medicine > Department of Medical Science > 1. Journal Articles
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.